PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 37 filers reported holding PROQR THRAPEUTICS N V in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $215,136 | -31.8% | 101,003 | +18.5% | 0.00% | -50.0% |
| Q4 2022 | $315,414 | +2326.3% | 85,247 | +492.0% | 0.00% | – |
| Q1 2022 | $13,000 | +116.7% | 14,400 | +1948.4% | 0.00% | – |
| Q4 2021 | $6,000 | -97.1% | 703 | -97.2% | 0.00% | -100.0% |
| Q3 2021 | $207,000 | -18.5% | 24,761 | -34.3% | 0.00% | 0.0% |
| Q2 2021 | $254,000 | +151.5% | 37,684 | +145.6% | 0.00% | +200.0% |
| Q1 2021 | $101,000 | +531.2% | 15,345 | +1539.4% | 0.00% | 0.0% |
| Q2 2015 | $16,000 | -94.4% | 936 | -92.8% | 0.00% | -92.9% |
| Q1 2015 | $286,000 | – | 13,064 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |